The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of intratumoral administration of the autologous immature dendritic cell (DC) vaccine used after lesion photodynamic therapy (PhDT) and immunomodulation with cyclophosphamide (Cy) in pretreated patients with disseminated malignant melanoma.
Alexey Viktorovich Novik
No relevant relationships to disclose
Irina Alexandrovma Baldueva
No relevant relationships to disclose
Mark Lvovich Gelfond
No relevant relationships to disclose
Svetlana Protsenko
No relevant relationships to disclose
Tatyana Leonidovna Nehaeva
No relevant relationships to disclose
Andrei Ivanovich Waal
No relevant relationships to disclose
Eugene Vladimirovich Vorobeychikov
No relevant relationships to disclose
Anna Borisovna Danilova
No relevant relationships to disclose
Alexey Olegovich Danilov
No relevant relationships to disclose
Anna Igorevna Semenova
No relevant relationships to disclose
Gulfiya Midhatovna Teletaeva
No relevant relationships to disclose
Vladimir Moiseyenko
No relevant relationships to disclose